FMR1, circadian genes and depression: Suggestive associations or false discovery?

Journal of Circadian Rhythms

Volumn 11, Issue 1, 2013, Pages

  Kripke, Daniel F ^a,b   Nievergelt, Caroline M ^a   Tranah, Gregory J ^c   Murray, Sarah S ^d,e   Rex, Katharine M ^a   Grizas, Alexandra P ^b   Hahn, Elizabeth K ^f   Lee, Heon Jeong ^g   Kelsoe, John R ^a,h,i   Kline, Lawrence E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS CLINIC   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

^g Korea University College of Medicine   (South Korea)

^h VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Circadian; Depression; DSPS; FMR1; GSK3B; NR1D1; PPARGC1B; rs25702; rs28900; rs7732671

Indexed keywords

CRYPTOCHROME 1; DNA; FRAGILE X MENTAL RETARDATION PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; MTNR1A PROTEIN; NPAS2 PROTEIN; NUCLEAR RECEPTOR NR1D1; PER3 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA C1B; RETINOID RELATED ORPHAN RECEPTOR ALPHA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CONTROLLED STUDY; DEPRESSION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; RECURRENT DISEASE; SELF CONCEPT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84875185805     PISSN: None     EISSN: 17403391     Source Type: Journal    
DOI: 10.1186/1740-3391-11-3     Document Type: Article

References (74)

1. Kripke DF, Mullaney DJ, Atkinson M, Wolf S. Circadian rhythm disorders in manic-depressives. Biol Psychiatry 1978, 13:335-351.
2. Andrade L, Caraveo-Anduaga JJ, Berglund P, Bijl RV, De GR, Vollebergh W. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res 2003, 12:3-21. 10.1002/mpr.138, 12830306.
3. Halberg F. Physiologic considerations underlying rhythmometry, with special reference to emotional illness. Symposium on biological cycles and psychiatry. Symposium Bell-Air III 1967, 73-126. Geneva: Mason et Cie.
4. Jenner FA, Gjessing LR, Cox JR, Vies-Jones A, Hullin RP, Hanna SM. A manic depressive psychotic with a persistent forty-eight hour cycle. Br J Psychiatry 1967, 113:895-910. 10.1192/bjp.113.501.895, 6048375.
5. Hodgson K, McGuffin P. The Genetic Basis of Depression 2013, Behav Neurosci: Curr Top.
6. Zhang EE, Liu AC, Hirota T, Miraglia LJ, Welch G, Pongsawakul PY. A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell 2009, 139:199-210. 10.1016/j.cell.2009.08.031, 2777987, 19765810.
7. Yan J, Wang H, Liu Y, Shao C. Analysis of gene regulatory networks in the mammalian circadian rhythm. PLoS Comput Biol 2008, 4:e1000193. 10.1371/journal.pcbi.1000193, 2543109, 18846204.
8. Edgar RS, Green EW, Zhao Y, Van OG, Olmedo M, Qin X. Peroxiredoxins are conserved markers of circadian rhythms. Nature 2012, 485:459-464. 3398137, 22622569.
9. Ukai H, Ueda HR. Systems biology of mammalian circadian clocks. Annu Rev Physiol 2010, 72:579-603. 10.1146/annurev-physiol-073109-130051, 20148689.
10. Albrecht U. Timing to perfection: the biology of central and peripheral circadian clocks. Neuron 2012, 74:246-260. 10.1016/j.neuron.2012.04.006, 22542179.
11. McCarthy MJ, Nievergelt CM, Kelsoe JR, Welsh DK. A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response. PLoS One 2012, 7:e32091. 10.1371/journal.pone.0032091, 3285204, 22384149.
12. Kessler RC. Epidemiology of women and depression. J Affect Disord 2003, 74:5-13. 10.1016/S0165-0327(02)00426-3, 12646294.
13. Kripke DF, Rex KM, Ancoli-Israel S, Nievergelt CM, Klimecki W, Kelsoe JR. Delayed sleep phase cases and controls. J Circadian Rhythms 2008, 6:1. 10.1186/1740-3391-6-1, 2249578, 18186932.
14. Emens J, Lewy A, Kinzie JM, Arntz D, Rough J. Circadian misalignment in major depressive disorder. Psychiatry Res 2009, 168:259-261. 10.1016/j.psychres.2009.04.009, 19524304.
15. Giglio LM, Magalhaes PV, Andersen ML, Walz JC, Jakobson L, Kapczinski F. Circadian preference in bipolar disorder. Sleep Breath 2010, 14:153-155. 10.1007/s11325-009-0301-3, 19774406.
16. Robillard R, Naismith SL, Rogers NL, Ip TK, Hermens DF, Scott EM. Delayed sleep phase in young people with unipolar or bipolar affective disorders. J Affect Disord 2013, 145:260-263. 10.1016/j.jad.2012.06.006, 22877966.
17. Zhang J, Fang Z, Jud C, Vansteensel MJ, Kaasik K, Lee CC. Fragile X-related proteins regulate mammalian circadian behavioral rhythms. Am J Hum Genet 2008, 83:43-52. 10.1016/j.ajhg.2008.06.003, 2443847, 18589395.
18. Santoro MR, Bray SM, Warren ST. Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective. Annu Rev Pathol 2012, 7:219-245. 10.1146/annurev-pathol-011811-132457, 22017584.
19. Willemsen R, Levenga J, Oostra BA. CGG repeat in the FMR1 gene: size matters. Clin Genet 2011, 80:214-225. 10.1111/j.1399-0004.2011.01723.x, 3151325, 21651511.
20. Roberts JE, Bailey DB, Mankowski J, Ford A, Sideris J, Weisenfeld LA. Mood and anxiety disorders in females with the FMR1 premutation. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:130-139. 10.1002/ajmg.b.30786, 18553360.
21. Hunter JE, Allen EG, Abramowitz A, Rusin M, Leslie M, Novak G. Investigation of phenotypes associated with mood and anxiety among male and female fragile X premutation carriers. Behav Genet 2008, 38:493-502. 10.1007/s10519-008-9214-3, 18535897.
22. Fatemi SH, Kneeland RE, Liesch SB, Folsom TD. Fragile X mental retardation protein levels are decreased in major psychiatric disorders. Schizophr Res 2010, 124:246-247. 10.1016/j.schres.2010.07.017, 2981618, 20727716.
23. Bourgeois JA, Seritan AL, Casillas EM, Hessl D, Schneider A, Yang Y. Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. J Clin Psychiatry 2011, 72:175-182. 10.4088/JCP.09m05407blu, 20816038.
24. Fiori LM, Zouk H, Himmelman C, Turecki G. X chromosome and suicide. Mol Psychiatry 2011, 16:216-226. 10.1038/mp.2009.132, 20010893.
25. Kripke DF, Shadan FF, Dawson A, Cronin JW, Jamil SM, Grizas AP. Genotyping sleep disorders patients. Psychiatry Investig 2010, 7:36-42. 10.4306/pi.2010.7.1.36, 2848776, 20396431.
26. Kripke DF, Nievergelt CM, Tranah GJ, Murray SS, McCarthy MJ, Rex KM. Polymorphisms in melatonin synthesis pathways: possible influences on depression. J Circadian Rhythms 2011, 9:8. 10.1186/1740-3391-9-8, 3177871, 21827647.
27. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN. The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinical rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003, 54:573-583. 10.1016/S0006-3223(02)01866-8, 12946886.
28. Doraiswamy PM, Bernstein IH, Rush AJ, Kyutoku Y, Carmody TJ, Macleod L. Diagnostic utility of the Quick Inventory of Depressive Symptomatology (QIDS-C16 and QIDS-SR16) in the elderly. Acta Psychiatr Scand 2010, 122:226-234. 10.1111/j.1600-0447.2009.01531.x, 20085556.
29. Lee HJ, Rex KM, Nievergelt CM, Kelsoe JR, Kripke DF. Delayed sleep phase syndrome is related to seasonal affective disorder. J Affect Disord 2011, 133:573-579. 10.1016/j.jad.2011.04.046, 3163003, 21601293.
30. Gottlieb DJ, O'Connor GT, Wilk JB. Genome-wide association of sleep and circadian phenotypes. BMC Med Genet 2007, 8(Suppl 1):S9. 10.1186/1471-2350-8-S1-S9, 1995620, 17903308.
31. Collins SC, Bray SM, Suhl JA, Cutler DJ, Coffee B, Zwick ME. Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males. Am J Med Genet A 2010, 152A:2512-2520. 10.1002/ajmg.a.33626, 2946449, 20799337.
32. Levinson DF, Zubenko GS, Crowe RR, DePaulo RJ, Scheftner WS, Weissman MM. Genetics of recurrent early-onset depression (GenRED): design and preliminary clinical characteristics of a repository sample for genetic linkage studies. Am J Med Genet B Neuropsychiatr Genet 2003, 119B:118-130. 10.1002/ajmg.b.20009, 12707949.
33. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991, 67:1047-1058. 10.1016/0092-8674(91)90283-5, 1760838.
34. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. Am J Hum Genet 2007, 81:559-575. 10.1086/519795, 1950838, 17701901.
35. Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, Scheftner WA. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 2011, 16:193-201. 10.1038/mp.2009.124, 20125088.
36. Boomsma DI, Willemsen G, Sullivan PF, Heutink P, Meijer P, Sondervan D. Genome-wide association of major depression: description of samples for the GAIN Major Depressive Disorder Study: NTR and NESDA biobank projects. Eur J Hum Genet 2008, 16:335-342. 10.1038/sj.ejhg.5201979, 18197199.
37. Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, Posthuma D. Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry 2011, 16:516-532. 10.1038/mp.2010.38, 20351714.
38. Wray NR, Pergadia ML, Blackwood DH, Penninx BW, Gordon SD, Nyholt DR. Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol Psychiatry 2012, 17:36-48. 10.1038/mp.2010.109, 3252611, 21042317.
39. Lewis CM, Ng MY, Butler AW, Cohen-Woods S, Uher R, Pirlo K. Genome-wide association study of major recurrent depression in the U.K. population. Am J Psychiatry 2010, 167:949-957. 10.1176/appi.ajp.2010.09091380, 20516156.
40. Schosser A, Butler AW, Ising M, Perroud N, Uher R, Ng MY. Genomewide association scan of suicidal thoughts and behaviour in major depression. PLoS One 2011, 6:e20690. 10.1371/journal.pone.0020690, 3130038, 21750702.
41. Durbin RM, Abecasis GR, Altshuler DL, Auton A, Brooks LD, Durbin RM. A map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073. 10.1038/nature09534, 3042601, 20981092.
42. Ladd PD, Smith LE, Rabaia NA, Moore JM, Georges SA, Hansen RS. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum Mol Genet 2007, 16:3174-3187. 10.1093/hmg/ddm293, 17921506.
43. Tassone F, De RS, Carosi C, La FG, Serpa G, Raske C. Differential usage of transcriptional start sites and polyadenylation sites in FMR1 premutation alleles. Nucleic Acids Res 2011, 39:6172-6185. 10.1093/nar/gkr100, 3152321, 21478165.
44. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD. Global variation in copy number in the human genome. Nature 2006, 444:444-454. 10.1038/nature05329, 2669898, 17122850.
45. Lubke GH, Hottenga JJ, Walters R, Laurin C, de Geus EJ, Willemsen G. Estimating the genetic variance of major depressive disorder due to all single nucleotide polymorphisms. Biol Psychiatry 2012, 72:707-709. 10.1016/j.biopsych.2012.03.011, 22520966.
46. Willour VL, Seifuddin F, Mahon PB, Jancic D, Pirooznia M, Steele J. A genome-wide association study of attempted suicide. Mol Psychiatry 2012, 17:433-444. 10.1038/mp.2011.4, 21423239.
47. Liu Y, Blackwood DH, Caesar S, de Geus EJ, Farmer A, Ferreira MA. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry 2011, 16:2-4. 10.1038/mp.2009.107, 20351715.
48. Muglia P, Tozzi F, Galwey NW, Francks C, Upmanyu R, Kong XQ. Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry 2010, 15:589-601. 10.1038/mp.2008.131, 19107115.
49. Rietschel M, Mattheisen M, Frank J, Treutlein J, Degenhardt F, Breuer R. Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biol Psychiatry 2010, 68:578-585. 10.1016/j.biopsych.2010.05.038, 20673876.
50. Fan M, Liu B, Jiang T, Jiang X, Zhao H, Zhang J. Meta-analysis of the association between the monoamine oxidase-A gene and mood disorders. Psychiatr Genet 2010, 20:1-7. 10.1097/YPG.0b013e3283351112, 20010318.
51. Zhang J, Chen Y, Zhang K, Yang H, Sun Y, Fang Y. A cis-phase interaction study of genetic variants within the MAOA gene in major depressive disorder. Biol Psychiatry 2010, 68:795-800. 10.1016/j.biopsych.2010.06.004, 20691428.
52. Galecki P, Szemraj J, Bartosz G, Bienkiewicz M, Galecka E, Florkowski A. Single-nucleotide polymorphisms and mRNA expression for melatonin synthesis rate-limiting enzyme in recurrent depressive disorder. J Pineal Res 2010, 48:311-317. 10.1111/j.1600-079X.2010.00754.x, 20433639.
53. Etain B, Dumaine A, Bellivier F, Pagan C, Francelle L, Goubran-Botros H. Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder. Hum Mol Genet 2012, 21:4030-4037. 10.1093/hmg/dds227, 22694957.
54. Dardente H, Wyse CA, Birnie MJ, Dupre SM, Loudon AS, Lincoln GA. A molecular switch for photoperiod responsiveness in mammals. Curr Biol 2010, 20:2193-2198. 10.1016/j.cub.2010.10.048, 21129971.
55. Masumoto KH, Ukai-Tadenuma M, Kasukawa T, Nagano M, Uno KD, Tsujino K. Acute induction of Eya3 by late-night light stimulation triggers TSHbeta expression in photoperiodism. Curr Biol 2010, 20:2199-2206. 10.1016/j.cub.2010.11.038, 21129973.
56. Soria V, Martinez-Amoros E, Escaramis G, Valero J, Crespo JM, Gutierrez-Zotes A. Resequencing and association analysis of arylalkylamine N-acetyltransferase (AANAT) gene and its contribution to major depression susceptibility. J Pineal Res 2010, 49:35-44.
57. McCarthy MJ, Nievergelt CM, Shekhtman T, Kripke DF, Welsh DK, Kelsoe JR. Functional genetic variation in the Rev-Erbalpha pathway and lithium response in the treatment of bipolar disorder. Genes Brain Behav 2011, 10:852-861. 10.1111/j.1601-183X.2011.00725.x, 3461952, 21781277.
58. Benedetti F, Bernasconi A, Lorenzi C, Pontiggia A, Serretti A, Colombo C. A single nucleotide polymorphism in glycogen synthase kinase 3-B promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 2004, 355:37-40. 10.1016/j.neulet.2003.10.021, 14729229.
59. Benedetti F, Serretti A, Pontiggia A, Bernasconi A, Lorenzi C, Colombo C. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-b -50 T/C SNP. Neurosci Lett 2005, 376:51-55. 10.1016/j.neulet.2004.11.022, 15694273.
60. Fitches A, Clark D, Joyce PR, Kennedy MA, Wells JE, Olds RJ. Association of alleles at GSK3B50 with bipolar disorder age of onset. Am J Hum Genet 2006, 141B(7):746.
61. Lachman HM, Pedrosa E, Petruolo OA, Cockerham M, Papolos A, Novak T. Increase in GSK3beta gene copy number variation in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2007, 144:259-265.
62. Luykx JJ, Boks MP, Terwindt AP, Bakker S, Kahn RS, Ophoff RA. The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies. Eur Neuropsychopharmacol 2010, 20:357-368. 10.1016/j.euroneuro.2010.02.008, 20226637.
63. Saus E, Soria V, Escaramis G, Crespo JM, Valero J, Gutierrez-Zotes A. A haplotype of glycogen synthase kinase 3beta is associated with early onset of unipolar major depression. Genes Brain Behav 2010, 9:799-807. 10.1111/j.1601-183X.2010.00617.x, 20618448.
64. Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P. Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder. Arch Gen Psychiatry 2009, 66:721-728. 10.1001/archgenpsychiatry.2009.70, 19581563.
65. Li X, Jope RS. Is glycogen synthase kinase-3 a central modulator in mood regulation?. Neuropsychopharmacol 2010, 35:2143-2154.
66. Yuskaitis CJ, Mines MA, King MK, Sweatt JD, Miller CA, Jope RS. Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome. Biochem Pharmacol 2010, 79:632-646. 10.1016/j.bcp.2009.09.023, 2810609, 19799873.
67. Lavebratt C, Sjoholm LK, Partonen T, Schalling M, Forsell Y. PER2 variation is associated with depression vulnerability. Am J Med Genet B Neuropsychiatr Genet 2009, 153:570-581.
68. Kovanen L, Saarikoski ST, Aromaa A, Lonnqvist J, Partonen T. ARNTL (BMAL1) and NPAS2 gene variants contribute to fertility and seasonality. PLoS One 2010, 5:e10007. 10.1371/journal.pone.0010007, 2848852, 20368993.
69. Garriock HA, Kraft JB, Shyn SI, Peters EJ, Yokoyama JS, Jenkins GD. A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry 2010, 67:133-138. 10.1016/j.biopsych.2009.08.029, 2794921, 19846067.
70. Terracciano A, Tanaka T, Sutin AR, Sanna S, Deiana B, Lai S. Genome-wide association scan of trait depression. Biol Psychiatry 2010, 68:811-817. 10.1016/j.biopsych.2010.06.030, 2955852, 20800221.
71. Kripke DF, Nievergelt CM, Joo EJ, Shekhtman T, Kelsoe JR. Circadian polymorphisms associated with affective disorders. J Circadian Rhythms 2009, 7:2. 10.1186/1740-3391-7-2, 2661876, 19166596.
72. Andreassen OA, Djurovic S, Thompson WK, Schork AJ, Kendler KS, O'Donovan MC. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet 2013, 92:197-209. 10.1016/j.ajhg.2013.01.001, 23375658.
73. Cavadini G, Petrzilka S, Kohler P, Jud C, Tobler I, Birchler T. TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc Natl Acad Sci USA 2007, 104:12843-12848. 10.1073/pnas.0701466104, 1937554, 17646651.
74. Hua P, Liu W, Zhao Y, Ding H, Wang L, Xiao H. Tef polymorphism is associated with sleep disturbances in patients with Parkinson's disease. Sleep Med 2012, 13:297-300. 10.1016/j.sleep.2011.06.023, 22257907.